Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Sanlam Writes Down AfroCentric to Nil but Won’t Sell

Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.

This article is for Health Matters subscribers

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in

More from Health Matters

06.11.2026

Pharmaceutical sovereignty is back in focus as Ebola spreads in the DRC. See how pooled procurement and shared regulation could secure supplies.

05.11.2026

Rare disease funding is under scrutiny after the KeyHealth ruling. See how schemes could share the cost of treatments such as Ultomiris.

05.11.2026

Essential medicine shortages threaten 165 public sector products in South Africa. See what is disrupting supply and how the department is responding.